CD274 and neoplasm: This unique sequence design enables the cSELP hydrogels to exhibit in situ gelation, photothermal responsive release of chemotherapeutic agent doxorubicin and immune checkpoint inhibitor anti‐PD‐L1, and antibacterial properties, leading to effective tumor microenvironment remodeling.